Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
IMNM
IMNM
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
IMNM News
Wall Street Analysts Adjust Ratings
3d ago
Benzinga
Precision Biologics Market Awakens to $71 Billion Opportunity
Feb 05 2026
Globenewswire
Precision Biologics Market Awakens to $71 Billion Opportunity
Feb 05 2026
Newsfilter
Market Overview: Energy Stocks Show Strength
Feb 01 2026
Benzinga
IMNM Options Analysis: Put Contract Offers 27.5% YieldBoost
Jan 13 2026
NASDAQ.COM
Insider Buying Update for Friday, December 19: IMNM and S
Dec 19 2025
NASDAQ.COM
Initial Week of IMNM Options Trading for February 2026
Dec 19 2025
NASDAQ.COM
Immunome Prices 18.625M Share Offering at $21.50, Raising Approximately $400 Million
Dec 17 2025
Newsfilter
Immunome Prices 18.625M Shares at $21.50, Raising Approximately $400 Million
Dec 17 2025
Businesswire
Immunome Reveals Pricing for Public Common Stock Offering
Dec 17 2025
Yahoo Finance
Oncolytics Biotech Secures FDA Approval with 33% Efficacy for New Drug
Dec 16 2025
Newsfilter
Oncolytics Biotech Secures FDA Approval with 33% Efficacy for Pelareorep in Colorectal Cancer
Dec 16 2025
Globenewswire
Stocks Decline Before US November Employment Data Release
Dec 16 2025
NASDAQ.COM
What’s Happening with Immunome Stock on Monday?
Dec 15 2025
Benzinga
Stocks Decline Amid Worries Over AI Investment
Dec 15 2025
NASDAQ.COM
Significant Options Activity on Monday: MO, IMNM, RSI
Dec 15 2025
NASDAQ.COM
Show More News
